(Total Views: 582)
Posted On: 01/18/2022 9:15:05 AM
Post# of 148878
gestalt,
The allowance of the meta analysis by the FDA is concerning the trial design of CD20 (20?) in the USA. The FDA is allowing meta analysis for the upcoming Phase 3 critical trial in the USA.
Nader, then said in the proactive video that he would ask Anvisa to allow the same for CD16 and 17 in Brazil.
Based on FDA precedence, I'm hopeful that it is allowed, meaning we could get to interim peek a lot sooner.
GL
The allowance of the meta analysis by the FDA is concerning the trial design of CD20 (20?) in the USA. The FDA is allowing meta analysis for the upcoming Phase 3 critical trial in the USA.
Nader, then said in the proactive video that he would ask Anvisa to allow the same for CD16 and 17 in Brazil.
Based on FDA precedence, I'm hopeful that it is allowed, meaning we could get to interim peek a lot sooner.
GL
(5)
(0)Scroll down for more posts ▼
